Comparison of amniotic fluid matrix metalloproteinase-8 and cathelicidin in the diagnosis of intra-amniotic infection

Journal of Perinatology

Volumn 36, Issue 12, 2016, Pages 1049-1054

  Myntti, T ^a   Rahkonen, L ^a   Patari Sampo A ^a   Tikkanen, M ^a   Sorsa, T ^b,c   Juhila, J ^d   Helve, O ^a   Andersson, S ^a   Paavonen, J ^a   Stefanovic, V ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Medix Biochemica   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; NEUTROPHIL COLLAGENASE; ANTIMICROBIAL CATIONIC PEPTIDE; BIOLOGICAL MARKER; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN;

ADULT; AMNION FLUID; AMNIONITIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MICROBIAL ACTIVITY; MICROBIAL INVASION OF THE AMNIOTIC CAVITY; PREDICTIVE VALUE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; AMNIOCENTESIS; CHEMISTRY; CHORIOAMNIONITIS; ENZYMOLOGY; GESTATIONAL AGE; METABOLISM; MICROBIOLOGY; PREGNANCY; PROSPECTIVE STUDY;

ADULT; AMNIOCENTESIS; AMNIOTIC FLUID; ANTIMICROBIAL CATIONIC PEPTIDES; BIOMARKERS; CHORIOAMNIONITIS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; MATRIX METALLOPROTEINASE 8; OBSTETRIC LABOR, PREMATURE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROSPECTIVE STUDIES; ROC CURVE;

EID: 84984820316     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2016.147     Document Type: Article

References (36)

1. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371(9606): 75-84.
2. Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol 2015; 213(4 Suppl): S29-S52.
3. Yoon BH, Romero R, Moon JB, Shim SS, Kim M, Kim G et al. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001; 185(5): 1130-1136.
4. Roescher AM, Timmer A, Erwich JJ, Bos AF. Placental pathology, perinatal death, neonatal outcome, and neurological development: a systematic review. PLoS One 2014; 9(2): e89419.
5. Garcia-Munoz Rodrigo F, Galan Henriquez GM, Ospina CG. Morbidity and mortality among very-low-birth-weight infants born to mothers with clinical chorioamnionitis. Pediatr Neonatol 2014; 55(5): 381-386.
6. Kim SM, Romero R, Park JW, Oh KJ, Jun JK, Yoon BH. The relationship between the intensity of intra-amniotic inflammation and the presence and severity of acute histologic chorioamnionitis in preterm gestation. J Matern Fetal Neonatal Med 2015; 28(13): 1500-1509.
7. Chafer-Pericas C, Stefanovic V, Sanchez-Illana A, Escobar J, Cernada M, Cubells E et al. Novel biomarkers in amniotic fluid for early assessment of intraamniotic infection. Free Radic Biol Med 2015; 89: 734-740.
8. Dulay AT, Buhimschi IA, Zhao G, Bahtiyar MO, Thung SF, Cackovic M et al. Compartmentalization of acute phase reactants Interleukin-6, C-reactive protein and procalcitonin as biomarkers of intra-amniotic infection and chorioamnionitis. Cytokine 2015; 76(2): 236-243.
9. Chaemsaithong P, Romero R, Korzeniewski SJ, Martinez-Varea A, Dong Z, Yoon BH et al. A point of care test for interleukin-6 in amniotic fluid in preterm prelabor rupture of membranes: a step toward the early treatment of acute intra-amniotic inflammation/infection. J Matern Fetal Neonatal Med 2016; 29(3): 360-367.
10. Chaemsaithong P, Romero R, Korzeniewski SJ, Martinez-Varea A, Dong Z, Yoon BH et al. A rapid interleukin-6 bedside test for the identification of intra-amniotic inflammation in preterm labor with intact membranes. J Matern Fetal Neonatal Med 2016; 29(3): 349-359.
11. Maymon E, Romero R, Chaiworapongsa T, Kim JC, Berman S, Gomez R et al. Value of amniotic fluid neutrophil collagenase concentrations in preterm premature rupture of membranes. Am J Obstet Gynecol 2001; 185(5): 1143-1148.
12. Park CW, Yoon BH, Kim SM, Park JS, Jun JK. The frequency and clinical significance of intra-amniotic inflammation defined as an elevated amniotic fluid matrix metalloproteinase-8 in patients with preterm labor and low amniotic fluid white blood cell counts. Obstet Gynecol Sci 2013; 56(3): 167-175.
13. Maymon E, Romero R, Pacora P, Gomez R, Athayde N, Edwin S et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol 2000; 183(1): 94-99.
14. Sorsa T, Tjaderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006; 38(5): 306-321.
15. Van Lint P, Libert C. Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev 2006; 17(4): 217-223.
16. Park CW, Moon KC, Park JS, Jun JK, Romero R, Yoon BH. The involvement of human amnion in histologic chorioamnionitis is an indicator that a fetal and an intra-amniotic inflammatory response is more likely and severe: clinical implications. Placenta 2009; 30(1): 56-61.
17. Angus SR, Segel SY, Hsu CD, Locksmith GJ, Clark P, Sammel MD et al. Amniotic fluid matrix metalloproteinase-8 indicates intra-amniotic infection. Am J Obstet Gynecol 2001; 185(5): 1232-1238.
18. Buhimschi CS, Bhandari V, Hamar BD, Bahtiyar MO, Zhao G, Sfakianaki AK et al. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med 2007; 4(1): e18.
19. Ramanathan B, Davis EG, Ross CR, Blecha F. Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes Infect 2002; 4(3): 361-372.
20. Wang G, Mishra B, Epand RF, Epand RM. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments. Biochim Biophys Acta 2014; 1838(9): 2160-2172.
21. Mendez-Samperio P. The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections. Peptides 2010; 31(9): 1791-1798.
22. Yoshio H, Tollin M, Gudmundsson GH, Lagercrantz H, Jornvall H, Marchini G et al. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr Res 2003; 53(2): 211-216.
23. Frew L, Makieva S, McKinlay AT, McHugh BJ, Doust A, Norman JE et al. Human cathelicidin production by the cervix. PLoS One 2014; 9(8): e103434.
24. Lim R, Barker G, Lappas M. Human cathelicidin antimicrobial protein 18 (hCAP18/LL-37) is increased in foetal membranes and myometrium after spontaneous labour and delivery. J Reprod Immunol 2015; 107: 31-42.
25. Tambor V, Kacerovsky M, Andrys C, Musilova I, Hornychova H, Pliskova L et al. Amniotic fluid cathelicidin in PPROM pregnancies: from proteomic discovery to assessing its potential in inflammatory complications diagnosis. PLoS One 2012; 7(7): e41164.
26. Wang G, Mishra B, Lau K, Lushnikova T, Golla R, Wang X. Antimicrobial peptides in 2014. Pharmaceuticals (Basel) 2015; 8(1): 123-150.
27. Kim SM, Romero R, Lee J, Mi Lee S, Park CW, Shin Park J et al. The frequency and clinical significance of intra-amniotic inflammation in women with preterm uterine contractility but without cervical change: do the diagnostic criteria for preterm labor need to be changed? J Matern Fetal Neonatal Med 2012; 25(8): 1212-1221.
28. Combs CA, Gravett M, Garite TJ, Hickok DE, Lapidus J, Porreco R et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol 2014; 210(2): 125. e1-125. e15.
29. Murtha AP, Edwards JM. The role of mycoplasma and ureaplasma in adverse pregnancy outcomes. Obstet Gynecol Clin North Am 2014; 41(4): 615-627.
30. Hitti J, Tarczy-Hornoch P, Murphy J, Hillier SL, Aura J, Eschenbach DA. Amniotic fluid infection, cytokines, and adverse outcome among infants at 34 weeks' gestation or less. Obstet Gynecol 2001; 98(6): 1080-1088.
31. Maki Y, Furukawa S, Kodama Y, Sameshima H, Ikenoue T. Amniocentesis for threatened preterm labor with intact membranes and the impact on adverse outcome in infants born at 22 to 28 weeks of gestation. Early Hum Dev 2015; 91(5): 333-337.
32. Porreco RP, Heyborne KD, Shapiro H. Amniocentesis in the management of preterm premature rupture of the membranes: a retrospective cohort analysis. J Matern Fetal Neonatal Med 2008; 21(8): 573-579.
33. Myntti T, Rahkonen L, Tikkanen M, Paavonen J, Stefanovic V. Vaginally obtained amniotic fluid samples in the diagnosis of subclinical chorioamnionitis. Acta Obstet Gynecol Scand 2016; 95(2): 233-237.
34. Garry D, Figueroa R, Aguero-Rosenfeld M, Martinez E, Visintainer P, Tejani N. A comparison of rapid amniotic fluid markers in the prediction of microbial invasion of the uterine cavity and preterm delivery. Am J Obstet Gynecol 1996; 175(5):1336-1341.
35. Greig PC, Ernest JM, Teot L. Low amniotic fluid glucose levels are a specific but not a sensitive marker for subclinical intrauterine infections in patients in preterm labor with intact membranes. Am J Obstet Gynecol 1994; 171(2): 365-370; discussion 370-1.
36. Myntti T, Rahkonen L, Tikkanen M, Patari-Sampo A, Paavonen J, Stefanovic V. Amniotic fluid rapid biomarkers are associated with intra-amniotic infection in preterm pregnancies regardless of the membrane status. J Perinatol 2016; 36: 606-611.